Research activities to improve the utilization of antibiotics in Africa

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 17, Issue 1, 2017, Pages 1-4

  Massele, Amos ^a   Tiroyakgosi, Celda ^b   Matome, Matshediso ^c   Desta, Abayneh ^d   Muller, Arno ^e   Paramadhas, Bene D Anand ^f,g   Malone, Brighid ^h   Kurusa, Gobuiwang ^h   Didimalang, Thatayaone ⁱ   Moyo, Mosana ⁱ   Godman, Brian ^j,k  

^a UNIVERSITY OF BOTSWANA   (Botswana)

^b Department of HIV AIDS Prevention and Care   (Botswana)

^c Managed Care   (Botswana)

^d WHO REGIONAL OFFICE FOR AFRICA   (Congo)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f Nyangabgwe Hospital   (Botswana)

^g UNIVERSITY OF SOUTH AFRICA   (South Africa)

^h Bokamoso Private Hospital   (Botswana)

ⁱ Gaborone Private Hospital   (Botswana)

^j KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^k UNIVERSITY OF STRATHCLYDE   (United Kingdom)

more..

Author keywords

Africa; Antibiotics; Botswana; MURIA; rational use

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CLARITHROMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

AFRICA; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; COST BENEFIT ANALYSIS; DRUG COST; DRUG EFFECT; DRUG UTILIZATION; ESCHERICHIA COLI; HELICOBACTER PYLORI; HUMAN; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; BOTSWANA; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; RESEARCH;

AFRICA; ANTI-BACTERIAL AGENTS; BOTSWANA; DRUG RESISTANCE, BACTERIAL; HUMANS; PRACTICE GUIDELINES AS TOPIC; RESEARCH;

EID: 84964063397     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/14737167.2016.1164040     Document Type: Article

References (23)

1. Md Rezal RS, Hassali MA, Alrasheedy AA, et al. Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing:a systematic review of the literature. Expert Rev Anti Infect Ther. 2015;13(5):665–680.•Discusses physician attitudes towards antibiotic prescribing and ways to enhance rational use.
2. Versporten A, Bolokhovets G, Ghazaryan L, et al. Antibiotic use in eastern Europe:a cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infect Dis. 2014;14(5):381–387.•• Providing a basis for comparing antibiotic utilisation across countries.
3. Huttner B, Goossens H, Verheij T, et al. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis. 2010;10(1):17–31.
4. Laxminarayan R, Matsoso P, Pant S, et al. Access to effective antimicrobials:a worldwide challenge. Lancet. 2016;387(10014):168–175.
5. Massele A, Burger J, Katende-Kyenda NL, et al. Outcome of the first medicines utilization research in Africa group meeting to promote sustainable and rational medicine use in Africa. Expert Rev Pharmacoecon Outcomes Res. 2015;15(6):885–888.
6. WHO Europe. The role of pharmacist in encouraging prudent use of antibiotics and averting antimicrobial resistance:a review of policy and experience. Available from:http://www.euro.who.int/__data/assets/pdf_file/0006/262815/The-role-of-pharmacist-in-encouraging-prudent-use-of-antibiotics-and-averting-antimicrobial-resistance-a-review-of-policy-and-experience-Eng.pdf?ua=1.
7. HM Government. Antimicrobial Resistance:Tackling a Crisis for the Health and Wealth of Nations. Available from:http://www.jpiamr.eu/wp-content/uploads/2014/12/AMR-Review-Paper-Tackling-a-crisis-for-the-health-and-wealth-of-nations_1-2.pdf.
8. Shallcross LJ, Davies SC., The World Health Assembly resolution on antimicrobial resistance. J Antimicrob Chemother. 2014;69(11):2883–2885.
9. Barnett ML, Linder JA. Antibiotic prescribing for adults with acute bronchitis in the United States, 1996–2010. JAMA. 2014;311(19):2020–2022.
10. Costelloe C, Metcalfe C, Lovering A, et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients:systematic review and meta-analysis. BMJ. 2010;340:c2096.
11. World Health Organisation. Review of antimicrobial resistance. Antimicrobial resistance:tackling a crisis for the health and wealth of nations. Available from:http://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf.•• Good study providing a review of current AMR rates and potential ways to reduce these.
12. O’Brien DJ, Gould IM. Maximizing the impact of antimicrobial stewardship:the role of diagnostics, national and international efforts. Curr Opin Infect Dis. 2013;26(4):352–358.•Benchmark study discussing antibiotic stewardship programmes.
13. Furst J, Cizman M, Mrak J, et al. The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade:findings and implications. Expert Rev Anti Infect Ther. 2015;13(2):279–289.•Good study emphasizing the need to undertake multiple interventions among all key stakeholder groups to reduce inappropriate prescribing of antibiotics.
14. Leung E, Weil DE, Raviglione M, et al. The WHO policy package to combat antimicrobial resistance. Bull World Health Organ. 2011;89(5):390–392.
15. Tafuma TA, Burnett RJ, Huis In ‘t Veld D. National guidelines not always followed when diagnosing smear-negative pulmonary tuberculosis in patients with HIV in Botswana. PloS One. 2014;9(2):e88654.
16. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2015. Available from:http://www.whocc.no/filearchive/publications/2015_guidelines.pdf.
17. Massele A, Godman B, Adorka M, et al. Initiative to progress research on medicine utilization in Africa:formation of the medicines utilization research in Africa group. Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):607–610.
18. Godman B, Wettermark B, Van Woerkom M, et al. Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures:findings and future implications. Front Pharmacol. 2014;5:106.
19. Holloway K, Mathai E, Gray A. Surveillance of community antimicrobial use in resource-constrained settings–experience from five pilot projects. Trop Med Int Health. 2011;16(2):152–161.•Good study discussing ways of ascertaining current antibiotic utilisation patterns in resource-constrained environments.
20. Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:Cd003543.
21. World Health Organisation. Drug and therapeutics committees - a practical guide. Available from:http://apps.who.int/medicinedocs/pdf/s4882e/s4882e.pdf.
22. European Centre for Disease Prevention and Control. Surveillance of antimicrobial consumption in Europe; 2012. Available from:http://ecdc.europa.eu/en/publications/Publications/antimicrobial-consumption-europe-esac-net-2012.pdf.
23. European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. 2011–2012. Available from:http://ecdc.europa.eu/en/publications/Publications/healthcare-associated-infections-antimicrobial-use-PPS.pdf.